| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Cytokinetics, Incorporated: Cytokinetics Announces FDA Approval of MYQORZO (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms | 1.493 | GlobeNewswire (Europe) | MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM FDA Approval Based on Results of SEQUOIA-HCM MYQORZO is Company's First FDA-Approved... ► Artikel lesen | |
| Fr | ROUNDUP/Aktien New York Schluss: Erholung geht weiter | 1.103 | dpa-AFX | NEW YORK (dpa-AFX) - Die US-Börsen haben sich am Freitag weiter von ihrem jüngsten Rücksetzer erholt. Eine Jahresendrally sei nach wie vor möglich, sagte ein Investmentexperte. Es herrschte unvermindert... ► Artikel lesen | |
| 07:00 | Canopy Growth legt stark zu. Kann Bioxyne ebenfalls auf der Welle reiten? | Small- & Micro Cap Investment | |||
| Breaking News: NurExone präsentiert unglaubliche Labordaten! | bullVestor | ||||
| Fr | Salarius Pharmaceuticals, Inc.: Salarius Pharmaceuticals Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting | 395 | GlobeNewswire (Europe) | HOUSTON, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) ("Salarius" or the "Company") today announced that its 2025 Annual Meeting of Stockholders (the "Annual Meeting")... ► Artikel lesen | |
| Fr | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 19.12.2025 | 358 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 19.12.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 19.12.2025ISIN NameCA74349R1055 PROPHECY... ► Artikel lesen | |
| Fr | Sharp Therapeutics Corp.: Sharp Therapeutics Provides Update on Non-Brokered Private Placement and Grant of Options | 324 | Newsfile | Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - December 19, 2025) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company"), is pleased to announce that... ► Artikel lesen | |
| Fr | Hansa Biopharma AB: Hansa Biopharma Submits BLA to FDA for Imlifidase in desensitization for Kidney Transplantation | 315 | PR Newswire | The application is based on the successful outcome of the pivotal US Phase 3 ConfIdeS trial in highly sensitized patientsImlifidase is an enzyme that rapidly and efficiently cleaves all types... ► Artikel lesen | |
| Fr | BioMarin Stock Surges Nearly 20% After $4.8 Bln Amicus Acquisition News | 294 | AFX News | WASHINGTON (dpa-AFX) - BioMarin Pharmaceutical Inc. (BMRN) shares rose 19.51%, climbing $10.13 to $62.08, after the company announced a definitive agreement to acquire Amicus Therapeutics for... ► Artikel lesen | |
| Fr | XFRA KK3A: AUSSETZUNG/SUSPENSION | 289 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCYTOKINETICS INC.... ► Artikel lesen | |
| Fr | Athira Pharma: Aktie knallt +170% nach NBC-Einstieg | 268 | sharedeals.de | Vorweihnachtliche Bescherung im No Brainer Club - und das am Fließband: Während Mitglieder noch mit dem Feiern der +167%-Rakete VYNE Therapeutics beschäftigt waren, schlug auch schon der nächste Volltreffer... ► Artikel lesen | |
| Fr | Berger Montague: SHAREHOLDER ALERT: Berger Montague Reminds Telix Pharmaceuticals Ltd. (TLX) Investors of Class Action Lawsuit Deadline | 237 | Newsfile | Philadelphia, Pennsylvania--(Newsfile Corp. - December 19, 2025) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Telix Pharmaceuticals... ► Artikel lesen | |
| Fr | Tiziana Life Sciences Ltd.: Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman | 208 | GlobeNewswire (Europe) | BOSTON, Dec. 19, 2025) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human... ► Artikel lesen | |
| Fr | OSR Holdings Inc.: Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings | 207 | PR Newswire | Company advancing dual clinical pathways, including a Samsung-supported PoC trial in Korea and a planned U.S. FDA trial with a leading California research university
... ► Artikel lesen | |
| Fr | NurExone Biologic Inc: NurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis | 105 | GlobeNewswire (Europe) | TORONTO and HAIFA, Israel, Dec. 19, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) ("NurExone" or the "Company") today announced new laboratory data demonstrating... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | Dividende 12M | Div.-Rendite | Erw. Dividende | Erw. Ex.-Datum | |
|---|---|---|---|---|---|---|
| AMGEN | 281,30 | 8,13 | +2,89 % | 2,52 | 13.02.2026 | |
| RECORDATI | 48,380 | 1,30 | +2,69 % | 0,63 | 24.11.2025 | |
| STRYKER | 304,30 | 2,90 | +0,95 % | 0,88 | 31.12.2025 | |
| BIO-TECHNE | 49,600 | 0,27 | +0,54 % | 0,08 | 17.11.2025 | |
| REGENERON PHARMACEUTICALS | 656,80 | 3,04 | +0,46 % | 0,88 | 20.11.2025 | |
| BIOGEN | 147,85 | 0,00 | 0,00 % | |||
| ENZO BIOCHEM | 0,388 | 0,00 | 0,00 % | |||
| MYRIAD GENETICS | 5,650 | 0,00 | 0,00 % | |||
| TRANSGENE | 0,904 | 0,00 | 0,00 % | |||
| INOVIO PHARMACEUTICALS | 2,020 | 0,00 | 0,00 % |